Giovanni Marchegiani

Giovanni Marchegiani: Prognostic factors in resected pancreatic cancer

Giovanni Marchegiani, Academic surgeon at Padova University Hospital, shared an article Ammar A Javed and colleagues authored on X:

“Prognostic factors in resected pancreatic cancer: personalized model according to neoadjuvant chemo

2.7k PDAC / 20% after NAT

NAT negative predictors are non normalized CA 19.9 / N+/ grade treatment response.”

Implications of Neoadjuvant Therapy on Prognostic Factors in Pancreatic Ductal Adenocarcinoma: A Path Towards Personalized Prognostication

Authors: Ammar A Javed et al.

Giovanni Marchegiani: Prognostic factors in resected pancreatic cancer

 

Ammar A. Javed Asad Fatimi Bas Groot Koerkam Brady A. Campbell Camila Hidalgo Salinas cancer Christopher L. Wolfgang Giovanni Marchegiani Hjalmar C. van Santvoort I Quintus Molenaar Ingmar F. Rompen Iris W.J.M. van Goor Jin He Joseph R. Habib Lois A Daamen Mahmud Omar Marc G Besselink OncoDaily Oncology Pancreatic Cancer Paul C.M. Andel Thijs J. Schouten Thomas F. Stoop